Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GALK1 |
| Upstream (Parents) |
|---|
| (<<) SHMT1 → GALK1 |
| (<<) RBKS → GALK1 |
| (<<) BTD → GALK1 |
| (<<) C21orf33 → GALK1 |
| Downstream (Children) |
|---|
| GALK1 → C17orf81 (>>) |
| GALK1 → MAB21L2 (>>) |
| GALK1 → LMO3 (>>) |
| GALK1 → PAX2 (>>) |
| GALK1 → MAGED4///MAGED4B (>>) |
| GALK1 → CRABP2 (>>) |
| GALK1 → SPEG (>>) |
| GALK1 → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P (>>) |
| GALK1 → HRK (>>) |
| GALK1 → TBCD (>>) |
| GALK1 → PNPLA4 (>>) |
